0001209191-16-141805.txt : 20160916
0001209191-16-141805.hdr.sgml : 20160916
20160916164609
ACCESSION NUMBER: 0001209191-16-141805
CONFORMED SUBMISSION TYPE: 4/A
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20160914
FILED AS OF DATE: 20160916
DATE AS OF CHANGE: 20160916
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: LEMAITRE VASCULAR INC
CENTRAL INDEX KEY: 0001158895
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 000000000
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 63 SECOND AVENUE
CITY: BURLINGTON
STATE: MA
ZIP: 01803
BUSINESS PHONE: 781-221-2266
MAIL ADDRESS:
STREET 1: 63 SECOND AVENUE
CITY: BURLINGTON
STATE: MA
ZIP: 01803
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Roberts David B
CENTRAL INDEX KEY: 0001365731
FILING VALUES:
FORM TYPE: 4/A
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-33092
FILM NUMBER: 161889857
MAIL ADDRESS:
STREET 1: 55 BRADFORD STREET
CITY: NEEDHAM
STATE: MA
ZIP: 02492
4/A
1
doc4a.xml
FORM 4/A SUBMISSION
X0306
4/A
2016-09-14
2016-09-16
0
0001158895
LEMAITRE VASCULAR INC
LMAT
0001365731
Roberts David B
C/O LEMAITRE VASCULAR, INC.
63 SECOND AVENUE
BURLINGTON
MA
01803
1
1
0
0
President and Director
Common Stock
2016-09-14
4
S
0
30000
20.3333
D
79793
D
Common Stock
2016-09-15
4
S
0
3548
21.0235
D
76245
D
The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.
The price reported in Column 4 is a weighted average price. The transaction was executed in multiple trades ranging from $20.18 to $20.55. The reporting person undertakes to provide to the issuer, any securityholder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and price at which the transaction was effected.
The price reported in Column 4 is a weighted average price. The transaction was executed in multiple trades ranging from $21.00 to $21.14. The reporting person undertakes to provide to the issuer, any securityholder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and price at which the transaction was effected.
This Form 4/A is filed solely to specify that the Reporting Person's sales were effected pursuant to a Rule 10b5-1 trading plan.
Laurie A. Churchill, Attorney-in-fact
2016-09-16